Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW). A Multicenter Randomized Controlled Clinical Trial.
Slebos DJ, Shah PL, Herth FJF, Pison C, Schumann C, Hübner RH, Bonta PI, Kessler R, Gesierich W, Darwiche K, Lamprecht B, Perez T, Skowasch D, Deslee G, Marceau A, Sciurba FC, Gosens R, Hartman JE, Srikanthan K, Duller M, Valipour A; AIRFLOW-2 Study Group. Slebos DJ, et al. Among authors: gosens r. Am J Respir Crit Care Med. 2019 Dec 15;200(12):1477-1486. doi: 10.1164/rccm.201903-0624OC. Am J Respir Crit Care Med. 2019. PMID: 31404499 Free PMC article. Clinical Trial.
Two-Year Outcomes for the Double-Blind, Randomized, Sham-Controlled Study of Targeted Lung Denervation in Patients with Moderate to Severe COPD: AIRFLOW-2.
Valipour A, Shah PL, Herth FJ, Pison C, Schumann C, Hübner RH, Bonta PI, Kessler R, Gesierich W, Darwiche K, Lamprecht B, Perez T, Skowasch D, Deslee G, Marceau A, Sciurba FC, Gosens R, Hartman JE, Conway F, Duller M, Mayse M, Norman HS, Slebos DJ; AIRFLOW-2 Trial Study Group. Valipour A, et al. Among authors: gosens r. Int J Chron Obstruct Pulmon Dis. 2020 Nov 5;15:2807-2816. doi: 10.2147/COPD.S267409. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 33177818 Free PMC article. Clinical Trial.
Targeted lung denervation modulates the mucosal epithelial transcriptome in COPD.
Srikanthan K, Kistemaker L, Slebos DJ, Gesierich W, Darwiche K, Bonta P, Deslee G, Shah P, Gosens R. Srikanthan K, et al. Among authors: gosens r. ERJ Open Res. 2022 Dec 27;8(4):00146-2022. doi: 10.1183/23120541.00146-2022. eCollection 2022 Oct. ERJ Open Res. 2022. PMID: 36578630 Free PMC article.
Activin-A: active in inflammation in COPD.
Tania NP, Schmidt M, Gosens R. Tania NP, et al. Among authors: gosens r. Eur Respir J. 2014 Apr;43(4):954-5. doi: 10.1183/09031936.00011414. Eur Respir J. 2014. PMID: 24687664 Free article. No abstract available.
microRNA-mRNA regulatory networks underlying chronic mucus hypersecretion in COPD.
Tasena H, Faiz A, Timens W, Noordhoek J, Hylkema MN, Gosens R, Hiemstra PS, Spira A, Postma DS, Tew GW, Grimbaldeston MA, van den Berge M, Heijink IH, Brandsma CA. Tasena H, et al. Among authors: gosens r. Eur Respir J. 2018 Sep 6;52(3):1701556. doi: 10.1183/13993003.01556-2017. Print 2018 Sep. Eur Respir J. 2018. PMID: 30072506 Free article.
191 results